Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes

TROP2 is a transmembrane glycoprotein that is overexpressed in various cancers. Emerging evidence suggests that TROP2-targeting therapies are efficacious and safe in patients with multiple prior treatments. TROP2 is a promising target for lung cancer treatment; however, little is known regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Inamura, Kentaro, Yokouchi, Yusuke, Kobayashi, Maki, Ninomiya, Hironori, Sakakibara, Rie, Subat, Sophia, Nagano, Hiroko, Nomura, Kimie, Okumura, Sakae, Shibutani, Tomoko, Ishikawa, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438686/
https://www.ncbi.nlm.nih.gov/pubmed/28404926
http://dx.doi.org/10.18632/oncotarget.15647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438686/
https://www.ncbi.nlm.nih.gov/pubmed/28404926
http://dx.doi.org/10.18632/oncotarget.15647

Ejemplares similares